The effects of sodium‐glucose cotransporter 2 inhibitors on left ventricular function: current evidence and future directions

Sodium‐glucose cotransporter 2 (SGLT2) inhibitors are a unique class of oral anti‐hyperglycaemic medications that act to reduce glucose reabsorption in the renal proximal tubules, thereby enhancing urinary glucose excretion. Large randomized placebo‐controlled trials in people with diabetes at high...

Descripción completa

Detalles Bibliográficos
Autores principales: Lan, Nick S.R., Fegan, P. Gerry, Yeap, Bu B., Dwivedi, Girish
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6816235/
https://www.ncbi.nlm.nih.gov/pubmed/31400090
http://dx.doi.org/10.1002/ehf2.12505

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6816235/
https://www.ncbi.nlm.nih.gov/pubmed/31400090
http://dx.doi.org/10.1002/ehf2.12505

Ejemplares similares